Patient | Age (years) | PSA at time of biopsy (ng/mL) | Time interval between MRI and PET (days) | Time interval between imaging and biopsy (days) | Time interval from biopsy to prostatectomy (days) | Volume of Gleason ≥ 7 disease at pathology (mL) | Standard biopsy highest Gleason score | Targeted biopsy highest Gleason score | Final maximum Gleason score at prostatectomy | Number of additional Gleason 3+3 cancers at prostatectomy |
---|---|---|---|---|---|---|---|---|---|---|
1 | 57 | 4.6 | 0 | 23 | 63 | 0.19 | 3 + 3 | 3 + 4 | 3 + 4 | 4 |
2 | 73 | 4.3 | 0 | 21 | 61 | 1.35 | 3 + 4 | Negative | 3 + 4 | 6 |
3 | 73 | 4.6 | 0 | 15 | 133 | 1.35 | 3 + 3 | 3 + 4 | 3 + 4 | 2 |
4 | 60 | 23.0 | 19 | 6 | 55 | 3.15 | 3 + 4 | 4 + 4 | 4 + 3 | 1 |
5** | 64 | 3.0 | 0 | 14 | 120 | 0.15 | 3 + 3 | 3 + 3 | 3 + 4 | 4 |
6 | 65 | 24.4 | 25 | 56 | 99 | 1.37 | Negative | 3 + 4 | 4 + 3 | 0 |
7 | 62 | 4.6 | 47 | 28 | 146 | 0.57 | Negative | 4 + 3 | 4 + 3 | 2 |
8 | 66 | 20.4 | 45 | 49 | 106 | 6.31 | 3 + 4 | 4 + 3 | 4 + 3 | 0 |
9 | 59 | 4.7 | 37 | 35 | 169 | 0.91 | 3 + 3 | 4 + 5 | 4 + 5 | 0 |
10 | 66 | 8.6 | 35 | 7 | 79 | 3.73 | Negative | 3 + 4 | 3 + 4 | 0 |